Literature DB >> 23078623

Complex role of γδ T-cell-derived cytokines and growth factors in cancer.

Andrew G Ramstead1, Mark A Jutila.   

Abstract

γδ T cells are innate lymphocytes that recognize and kill a range of tumor cells and are currently being explored as a target for tumor immunotherapy. However, γδ T cells play a complex role in cancer and can promote, as well as inhibit, tumor growth. In addition to tumor cell killing, γδ T cells express a number of cytokines and other soluble factors in response to tumors. Soluble factors expressed by γδ T cells in these settings include interferon-γ, tumor necrosis factor-α, interleukin (IL)-4, IL-10, transforming growth factor-β, IL-17, and a number of growth factors. These factors have differing and sometimes opposing effects on antitumor immunity and tumor angiogenesis, and likely contribute to the complex role of these cells in cancer. Here, we review studies in both mice and humans that examine differential cytokine secretion by γδ T cells in response to tumors and tumor immunotherapy, and discuss the influence of these γδ T-cell-derived factors on tumor growth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23078623      PMCID: PMC3514002          DOI: 10.1089/jir.2012.0073

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  61 in total

1.  A role for skin gammadelta T cells in wound repair.

Authors:  Julie Jameson; Karen Ugarte; Nicole Chen; Pia Yachi; Elaine Fuchs; Richard Boismenu; Wendy L Havran
Journal:  Science       Date:  2002-04-26       Impact factor: 47.728

2.  Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.

Authors:  Francesco Dieli; David Vermijlen; Fabio Fulfaro; Nadia Caccamo; Serena Meraviglia; Giuseppe Cicero; Andrew Roberts; Simona Buccheri; Matilde D'Asaro; Nicola Gebbia; Alfredo Salerno; Matthias Eberl; Adrian C Hayday
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 3.  Current progress in γδ T-cell biology.

Authors:  Jianlei Hao; Xiaoli Wu; Siyuan Xia; Zheng Li; Ti Wen; Na Zhao; Zhenzhou Wu; Puyue Wang; Liqing Zhao; Zhinan Yin
Journal:  Cell Mol Immunol       Date:  2010-10-11       Impact factor: 11.530

Review 4.  Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.

Authors:  Barbara Castella; Candida Vitale; Marta Coscia; Massimo Massaia
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

5.  Activation of V gamma 9V delta 2 T cells by NKG2D.

Authors:  Bladimiro Rincon-Orozco; Volker Kunzmann; Philine Wrobel; Dieter Kabelitz; Alexander Steinle; Thomas Herrmann
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

6.  Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinoma.

Authors:  Kia Joo Puan; John Seng Hooi Low; Terence Wee Kiat Tan; Joseph Tien Seng Wee; Eng Huat Tan; Kam Weng Fong; Eu Tiong Chua; Chenggang Jin; José-Luis Giner; Craig T Morita; Christopher Hood Keng Goh; Kam M Hui
Journal:  Cancer Immunol Immunother       Date:  2008-11-30       Impact factor: 6.968

7.  Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.

Authors:  Guangyong Peng; Helen Y Wang; Weiyi Peng; Yukiko Kiniwa; Kook Heon Seo; Rong-Fu Wang
Journal:  Immunity       Date:  2007-07-26       Impact factor: 31.745

8.  Expression and synthesis of fibroblast growth factor-9 in human gammadelta T-lymphocytes. Response to isopentenyl pyrophosphate and TGF-beta1/IL-15.

Authors:  Grefachew Workalemahu; Martin Foerster; Claus Kroegel
Journal:  J Leukoc Biol       Date:  2004-01-02       Impact factor: 4.962

9.  Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.

Authors:  Yuting Ma; Laetitia Aymeric; Clara Locher; Stephen R Mattarollo; Nicolas F Delahaye; Pablo Pereira; Laurent Boucontet; Lionel Apetoh; François Ghiringhelli; Noëlia Casares; Juan José Lasarte; Goro Matsuzaki; Koichi Ikuta; Bernard Ryffel; Kamel Benlagha; Antoine Tesnière; Nicolas Ibrahim; Julie Déchanet-Merville; Nathalie Chaput; Mark J Smyth; Guido Kroemer; Laurence Zitvogel
Journal:  J Exp Med       Date:  2011-03-07       Impact factor: 14.307

10.  Gamma delta T cells provide an early source of interferon gamma in tumor immunity.

Authors:  Yunfei Gao; Wancai Yang; Meng Pan; Eileen Scully; Michael Girardi; Leonard H Augenlicht; Joe Craft; Zhinan Yin
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  10 in total

Review 1.  γδ T Cells: Unexpected Regulators of Cancer Development and Progression.

Authors:  Christopher Fleming; Samantha Morrissey; Yihua Cai; Jun Yan
Journal:  Trends Cancer       Date:  2017-07-17

Review 2.  Mechanisms and applications of interleukins in cancer immunotherapy.

Authors:  Doxakis Anestakis; Savvas Petanidis; Spyridon Kalyvas; Christiane M Nday; Olga Tsave; Efrosini Kioseoglou; Athanasios Salifoglou
Journal:  Int J Mol Sci       Date:  2015-01-13       Impact factor: 5.923

3.  Activation of cellular immunity and marked inhibition of liver cancer in a mouse model following gene therapy and tumor expression of GM-SCF, IL-21, and Rae-1.

Authors:  Mingrong Cheng; Kangkang Zhi; Xiaoyan Gao; Bing He; Yingchun Li; Jiang Han; Zhiping Zhang; Yan Wu
Journal:  Mol Cancer       Date:  2013-12-18       Impact factor: 27.401

Review 4.  Gamma-delta (γδ) T cells: friend or foe in cancer development?

Authors:  Yijing Zhao; Chao Niu; Jiuwei Cui
Journal:  J Transl Med       Date:  2018-01-10       Impact factor: 5.531

Review 5.  γδ T Cells: The Ideal Tool for Cancer Immunotherapy.

Authors:  Mahboubeh Yazdanifar; Giulia Barbarito; Alice Bertaina; Irma Airoldi
Journal:  Cells       Date:  2020-05-24       Impact factor: 6.600

Review 6.  Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity.

Authors:  Nilberto Dias de Araújo; Fábio Magalhães Gama; Mateus de Souza Barros; Thaís Lohana Pereira Ribeiro; Fabíola Silva Alves; Lilyane Amorim Xabregas; Andréa Monteiro Tarragô; Adriana Malheiro; Allyson Guimarães Costa
Journal:  J Immunol Res       Date:  2021-01-07       Impact factor: 4.818

Review 7.  Bibliometric Analysis of γδ T Cells as Immune Regulators in Cancer Prognosis.

Authors:  Bing Liu; Xu He; Yong Wang; Jian-Wen Huang; You-Bing Zheng; Yong Li; Li-Gong Lu
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

8.  m6A-Related Angiogenic Genes to Construct Prognostic Signature, Reveal Immune and Oxidative Stress Landscape, and Screen Drugs in Hepatocellular Carcinoma.

Authors:  Xiaodong Qu; Luyao Zhang; Songbo Li; Tian Li; Xingyu Zhao; Na Wang; Yongquan Shi
Journal:  Oxid Med Cell Longev       Date:  2022-09-30       Impact factor: 7.310

9.  Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells.

Authors:  Mingrong Cheng; Hongzhi Xu; Yong Wang; Houxiang Chen; Bing He; Xiaoyan Gao; Yingchun Li; Jiang Han; Zhiping Zhang
Journal:  Drug Des Devel Ther       Date:  2013-10-25       Impact factor: 4.162

Review 10.  A Cell for the Ages: Human γδ T Cells across the Lifespan.

Authors:  Brandi L Clark; Paul G Thomas
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.